Yuan Hui-Zhi, Zhu Xue-Yan, Yang Li-Ming, Zhang Xiao-Xuan, Li Xin-Yang, Xie Tong, Zhai Jing-Zhu, Zhuang Xiao-Hua, Cui Wen-Peng
Department of Nephrology,the Second Hospital of Jilin University,Changchun 130041,China.
Department of Nephrology,Jilin Central Hospital,Jilin,Jilin 132011,China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023 Apr;45(2):227-234. doi: 10.3881/j.issn.1000-503X.15138.
Objective To investigate the treatment outcomes,prognosis,and risk factors of treatment failure of peritoneal dialysis associated peritonitis (PDAP) caused by ,and thus provide clinical evidence for the prevention and treatment of this disease. Methods The clinical data of PDAP patients at four peritoneal dialysis centers from January 1,2014 to December 31,2019 were collected retrospectively.The treatment outcomes and prognosis were compared between the patients with PDAP caused by and that caused by Kaplan-Meier method was employed to establish the survival curve of technical failure,and multivariate Logistic regression to analyze the risk factors of the treatment failure of PADP caused by . Results In the 4 peritoneal dialysis centers,1034 cases of PDAP occurred in 586 patients from 2014 to 2019,including 21 cases caused by and 98 cases caused by .The incidence of caused PDAP was 0.0048 times per patient per year on average,ranging from 0.0024 to 0.0124 times per patient per year during 2014-2019.According to the Kaplan-Meier survival curve,the technical failure rate of caused PDAP was higher than that of caused PDAP (=0.022).The multivariate Logistic regression model showed that long-term dialysis was an independent risk factor for the treatment failure of caused PDAP (=1.082,95%=1.011-1.158,=0.023). was highly sensitive to amikacin,meropenem,imipenem,piperacillin,and cefotetan,and it was highly resistant to ampicillin (81.82%),cefazolin (53.33%),tetracycline (50.00%),cefotaxime (43.75%),and chloramphenicol (42.86%). Conclusion The PDAP caused by had worse prognosis than that caused by ,and long-term dialysis was an independent risk factor for the treatment failure of caused PDAP.
目的 探讨由[具体病原体名称未给出]引起的腹膜透析相关性腹膜炎(PDAP)的治疗效果、预后及治疗失败的危险因素,从而为该病的防治提供临床依据。方法 回顾性收集2014年1月1日至2019年12月31日四个腹膜透析中心PDAP患者的临床资料。比较由[具体病原体名称未给出]引起的PDAP患者与由[具体病原体名称未给出]引起的PDAP患者的治疗效果和预后,采用Kaplan-Meier法建立技术失败生存曲线,多因素Logistic回归分析由[具体病原体名称未给出]引起的PADP治疗失败的危险因素。结果 在4个腹膜透析中心,2014年至2019年586例患者发生1034例PDAP,其中由[具体病原体名称未给出]引起21例,由[具体病原体名称未给出]引起98例。由[具体病原体名称未给出]引起的PDAP平均发病率为每年每位患者0.0048次,2014 - 2019年期间每年每位患者0.0024至0.0124次。根据Kaplan-Meier生存曲线,由[具体病原体名称未给出]引起的PDAP技术失败率高于由[具体病原体名称未给出]引起的PDAP(P = 0.022)。多因素Logistic回归模型显示,长期透析是由[具体病原体名称未给出]引起的PDAP治疗失败的独立危险因素(P = 1.082,95%CI = 1.011 - 1.158,P = 0.023)。[具体病原体名称未给出]对阿米卡星、美罗培南、亚胺培南、哌拉西林和头孢替坦高度敏感,对氨苄西林(81.82%)、头孢唑林(53.33%)、四环素(50.00%)、头孢噻肟(43.75%)和氯霉素(42.86%)高度耐药。结论 由[具体病原体名称未给出]引起的PDAP预后比由[具体病原体名称未给出]引起的PDAP差,长期透析是由[具体病原体名称未给出]引起的PDAP治疗失败的独立危险因素。